Inhibitors of Galectins and Implications for Structure-Based Design of Galectin-Specific Therapeutics

被引:22
|
作者
Blanchard, Helen [1 ]
Bum-Erdene, Khuchtumur [1 ]
Hugo, Matthew W. [1 ]
机构
[1] Griffith Univ, Inst Glyc, Gold Coast Campus, Qld 4222, Australia
关键词
MODIFIED CITRUS PECTIN; CYCLODEXTRIN-BASED GLYCOCLUSTERS; ARGININE-ARENE INTERACTIONS; PROSTATE-CANCER; MAMMALIAN GALECTINS; TETRAVALENT GLYCOCLUSTERS; INDUCED APOPTOSIS; CELL APOPTOSIS; MESSENGER-RNA; TUMOR-GROWTH;
D O I
10.1071/CH14362
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Galectins are a family of galactoside-specific lectins that are involved in a myriad of metabolic and disease processes. Due to roles in cancer and inflammatory and heart diseases, galectins are attractive targets for drug development. Over the last two decades, various strategies have been used to inhibit galectins, including polysaccharide-based therapeutics, multivalent display of saccharides, peptides, peptidomimetics, and saccharide-modifications. Primarily due to galectin carbohydrate binding sites having high sequence identities, the design and development of selective inhibitors targeting particular galectins, thereby addressing specific disease states, is challenging. Furthermore, the use of different inhibition assays by research groups has hindered systematic assessment of the relative selectivity and affinity of inhibitors. This review summarises the status of current inhibitors, strategies, and novel scaffolds that exploit subtle differences in galectin structures that, in conjunction with increasing available data on multiple galectins, is enabling the feasible design of effective and specific inhibitors of galectins.
引用
收藏
页码:1763 / 1779
页数:17
相关论文
共 50 条
  • [21] The structure-based design of inhibitors to the cytotoxin ricin
    Robertus, JD
    Sawyer, G
    Schleit, J
    Kerwin, S
    Dilek, I
    Madal, S
    PROTEIN SCIENCE, 2004, 13 : 129 - 130
  • [22] Structure-based design of dual AChE and BACE-1 inhibitors as potential therapeutics for neurodegenerative diseases
    Gabr, Moustafa
    Abdel-Raziq, Mohammed
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [23] Structures of human cytosolic and mitochondrial nucleotidases: implications for structure-based design of selective inhibitors
    Pachl, Petr
    Fabry, Milan
    Rosenberg, Ivan
    Simak, Ondrej
    Rezacova, Pavlina
    Brynda, Jiri
    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2014, 70 : 461 - 470
  • [24] Development of Cathepsin Inhibitors and Structure-Based Design of Cathepsin B-Specific Inhibitor
    Tomoo, Koji
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (07) : 696 - 707
  • [25] Structure-Based Design of a Monosaccharide Ligand Targeting Galectin-8
    Bohari, Mohammad H.
    Yu, Xing
    Kishor, Chandan
    Patel, Brijesh
    Go, Rob Marc
    Seyedi, Hadieh A. Eslampanah
    Vinik, Yaron
    Grice, I. Darren
    Zick, Yehiel
    Blanchard, Helen
    CHEMMEDCHEM, 2018, 13 (16) : 1664 - 1672
  • [26] Structure-based drug design of pyruvate kinase inhibitors
    Maxwell, David S.
    Peng, Zhenghong
    Sun, Duoli
    Yung, W. K. Alfred
    Lu, Zhimin
    Bornmann, William G.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [27] Structure-based design and synthesis of aspartyl protease inhibitors
    Ghosh, AK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2642 - U2642
  • [28] Advances in the Structure-Based Design of the Influenza A Neuraminidase Inhibitors
    Mitrasinovic, Petar M.
    CURRENT DRUG TARGETS, 2010, 11 (03) : 315 - 326
  • [29] Structure-based design of bacterial hyaluronan lyase inhibitors
    Botzki, A
    Salmen, S
    Bernhardt, G
    Buschauer, A
    Dove, S
    QSAR & COMBINATORIAL SCIENCE, 2005, 24 (04): : 458 - 469
  • [30] Structure-based design of PDK1 inhibitors
    Poulsen, Anders
    Blanchard, Stephanie
    Soh, Chang Kai
    Lee, Chaiping
    Williams, Meredith
    Wang, Haishan
    Dymock, Brian
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 305 - 307